(AFX UK Focus) 2009-09-03 08:36 India's Ranbaxy to launch generic Rocaltrol in U.S. (Interactive Investor) PDF Print

BANGALORE, Sept 3 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd said on Thursday it would launch in the United States a generic version of Rocaltrol used in the treatment of ailments arising from renal failure. Ranbaxy will market the drug, which has annual sales worth $70 million, in an agreement with Validus Pharmaceuticals, a U.S.-based company focused on acquiring and marketing ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.